Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma (rrMZL) Patients Treated with Zanubrutinib in the MAGNOLIA Trial

Matciek Tatarczuch; Mark C. Waltham; Jake Shortt; Galina Polekhina; Eliza A. Hawkes; Shir Jing Ho; Judith Trotman; Daniella Brasacchio; Melannie Co; Jessica Li; Vanitha Ramakrishnan; Karin Dunne; Stephen S. Opat; Gareth P. Gregory

Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma (rrMZL) Patients Treated with Zanubrutinib in the MAGNOLIA Trial

Matciek Tatarczuch, Mark C. Waltham, Jake Shortt, Galina Polekhina, Eliza A. Hawkes, Shir Jing Ho, Judith Trotman, Daniella Brasacchio, Melannie Co, Jessica Li, Vanitha Ramakrishnan, Karin Dunne, Stephen S. Opat, Gareth P. Gregory

Research output: Contribution to conference › Abstract › peer-review

Original language	English
Pages	99
Number of pages	1
Publication status	Published - 2022
Event	Blood 2022 - Sydney international Convention Centre, Sydney, Australia Duration: 11 Sept 2022 → 14 Sept 2022 https://www.hsanz.org.au/blood-annual-conference/11140994 https://www.hsanz.org.au/resources/Documents/Final_Abstract_Book%20Blood%202022.pdf (Abstract Book - copy also saved in the ROCS S drive folder) https://www.hsanz.org.au/archive

Conference

Conference	Blood 2022
Country/Territory	Australia
City	Sydney
Period	11/09/22 → 14/09/22
Internet address	https://www.hsanz.org.au/blood-annual-conference/11140994 https://www.hsanz.org.au/resources/Documents/Final_Abstract_Book%20Blood%202022.pdf (Abstract Book - copy also saved in the ROCS S drive folder) https://www.hsanz.org.au/archive

Access to Document

https://www.hsanz.org.au/resources/Documents/Final_Abstract_Book%20Blood%202022.pdf

Cite this

Tatarczuch, M., Waltham, M. C., Shortt, J., Polekhina, G., Hawkes, E. A., Ho, S. J., Trotman, J., Brasacchio, D., Co, M., Li, J., Ramakrishnan, V., Dunne, K., Opat, S. S., & Gregory, G. P. (2022). Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma (rrMZL) Patients Treated with Zanubrutinib in the MAGNOLIA Trial . 99. Abstract from Blood 2022, Sydney, New South Wales, Australia. https://www.hsanz.org.au/resources/Documents/Final_Abstract_Book%20Blood%202022.pdf

@conference{20957e338d864d9880151e34baaa0934,

title = "Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma (rrMZL) Patients Treated with Zanubrutinib in the MAGNOLIA Trial ",

author = "Matciek Tatarczuch and Waltham, \{Mark C.\} and Jake Shortt and Galina Polekhina and Hawkes, \{Eliza A.\} and Ho, \{Shir Jing\} and Judith Trotman and Daniella Brasacchio and Melannie Co and Jessica Li and Vanitha Ramakrishnan and Karin Dunne and Opat, \{Stephen S.\} and Gregory, \{Gareth P.\}",

year = "2022",

language = "English",

pages = "99",

note = "Blood 2022 ; Conference date: 11-09-2022 Through 14-09-2022",

url = "https://www.hsanz.org.au/blood-annual-conference/11140994, https://www.hsanz.org.au/resources/Documents/Final\_Abstract\_Book\%20Blood\%202022.pdf, https://www.hsanz.org.au/archive",

}

Tatarczuch, M, Waltham, MC , Shortt, J, Polekhina, G, Hawkes, EA, Ho, SJ, Trotman, J, Brasacchio, D, Co, M, Li, J, Ramakrishnan, V, Dunne, K, Opat, SS & Gregory, GP 2022, 'Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma (rrMZL) Patients Treated with Zanubrutinib in the MAGNOLIA Trial ', Blood 2022, Sydney, Australia, 11/09/22 - 14/09/22 pp. 99. <https://www.hsanz.org.au/resources/Documents/Final_Abstract_Book%20Blood%202022.pdf>

Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21: Molecular Correlates of Response in Relapsed/Refractory Marginal Zone Lymphoma (rrMZL) Patients Treated with Zanubrutinib in the MAGNOLIA Trial . / Tatarczuch, Matciek; Waltham, Mark C.; Shortt, Jake et al.
2022. 99 Abstract from Blood 2022, Sydney, New South Wales, Australia.

Research output: Contribution to conference › Abstract › peer-review

TY - CONF

T1 - Australasian Leukaemia and Lymphoma Group (ALLG) Laboratory Science Study LS21

T2 - Blood 2022

AU - Tatarczuch, Matciek

AU - Waltham, Mark C.

AU - Shortt, Jake

AU - Polekhina, Galina

AU - Hawkes, Eliza A.

AU - Ho, Shir Jing

AU - Trotman, Judith

AU - Brasacchio, Daniella

AU - Co, Melannie

AU - Li, Jessica

AU - Ramakrishnan, Vanitha

AU - Dunne, Karin

AU - Opat, Stephen S.

AU - Gregory, Gareth P.

PY - 2022

Y1 - 2022

M3 - Abstract

SP - 99

Y2 - 11 September 2022 through 14 September 2022

ER -